Type 2 diabetes patients | Controls | |||
---|---|---|---|---|
(n = 90) | (n = 90) | |||
β ± SE pr μg/mL plasma fibulin-1 | P-value | β ± SE pr μg/mL plasma fibulin-1 | P-value | |
Age (years) | 0.5 ± 0.3 | 0.10 | 0.12 ± 0.32 | 0.71 |
HbA1c (%) | −3.8 ± 4.7 | 0.42 | 9.3 ± 9.3 | 0.32 |
Body Mass Index (kg/m2) | −1.1 ± 0.6 | 0.10 | −0.01 ± 0.81 | 0.99 |
Plasma total cholesterol (mmol/l) | 0.59 ± 3.84 | 0.88 | 2.33 ± 3.10 | 0.45 |
Plasma creatinine (μmol/liter) | 0.24 ± 0.21 | 0.25 | −0.41 ± 0.22 | 0.07 |
Estimated glomerular filtration rate (mL/min/1.73 m2) | −0.40 ± 0.19 | <0.05 | −0.11 ± 0.25 | 0.65 |
Ln-transformed Urine albumine/creatinine ratio (mg/mmol) | 1.83 ± 3.10 | 0.55 | 4.26 ± 3.8 | 0.27 |
Office systolic BP (mmHg) | −0.06 ± 0.18 | 0.74 | −0.14 ± 0.18 | 0.43 |
Office diastolic BP (mmHg) | −0.33 ± 0.35 | 0.36 | −0.34 ± 0.32 | 0.28 |
Office pulse pressure (mmHg) | 0.04 ± 0.23 | 0.86 | −0.07 ± 0.26 | 0.80 |
Office heart rate (beats/min) | 0.01 ± 0.20 | 0.98 | −0.15 ± 0.34 | 0.66 |
24-h ABPM systolic BP (mmHg) | −0.31 ± 0.28 | 0.26 | −0.13 ± 0.28 | 0.63 |
24-h ABPM diastolic BP (mmHg) | −0.78 ± 0.40 | 0.053 | −0.24 ± 0.43 | 0.58 |
24-h ABPM pulse pressure (mmHg) | 0.08 ± 0.36 | 0.82 | −0.07 ± 0.38 | 0.86 |
24-h ABPM heart rate (beats/min) | 0.22 ± 0.32 | 0.70 | −0.40 ± 0.34 | 0.25 |